comprehensive -WSS

comprehensive

author：comprehensive 2025-09-02 08:25:54 - browse：951

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Doctors increasingly discourage vaping amid mounting health concerns

Wikipedia

WSS

Pharma companies must ensure equitable access to obesity drugs

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Coercive sterilizations revealed by STAT prompt outrage

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

5 takeaways from STAT's examination of Zynex Medical

Doctors in states that ban abortion can still help patients

knowledge

comprehensive

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Doctors increasingly discourage vaping amid mounting health concerns

Affirmative action in medical school literally saved lives

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

HCA says smaller share of spending going to labor

Drug repurposing or repositioning? The language matters

How faith leaders like me can help address America's obesity epidemic

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The system is set up to fail children with medical complexity

explore

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Cigna wins case to block Amy Bricker's move to CVS

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

'Weather

Cigna wins case to block Amy Bricker's move to CVS

Report captures long Covid’s disabling effects and policy challenges

leisure time

Wikipedia

Wikipedia

hotspot